AAPM medical physics practice guideline 13.a: HDR brachytherapy, part A - PubMed (original) (raw)

Practice Guideline

AAPM medical physics practice guideline 13.a: HDR brachytherapy, part A

Susan L Richardson et al. J Appl Clin Med Phys. 2023 Mar.

Abstract

The American Association of Physicists in Medicine (AAPM) is a nonprofit professional society whose primary purposes are to advance the science, education, and professional practice of medical physics. The AAPM has more than 8000 members and is the principal organization of medical physicists in the United States. The AAPM will periodically define new practice guidelines for medical physics practice to help advance the science of medical physics and to improve the quality of service to patients throughout the United States. Existing medical physics practice guidelines (MPPGs) will be reviewed for the purpose of revision or renewal, as appropriate, on their fifth anniversary or sooner. Each medical physics practice guideline represents a policy statement by the AAPM, has undergone a thorough consensus process in which it has been subjected to extensive review, and requires the approval of the Professional Council. The medical physics practice guidelines recognize that the safe and effective use of diagnostic and therapeutic radiology requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice guidelines and technical standards by those entities not providing these services is not authorized. The following terms are used in the AAPM practice guidelines: (1) Must and must not: Used to indicate that adherence to the recommendation is considered necessary to conform to this practice guideline. (2) Should and should not: Used to indicate a prudent practice to which exceptions may occasionally be made in appropriate circumstances. Approved by AAPM's Executive Committee April 28, 2022.

Keywords: HDR; MPPG; brachytherapy; practice guideline.

© 2023 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.

PubMed Disclaimer

Conflict of interest statement

The Chair of TG 348: MPPG 13.1: HDR Brachytherapy has reviewed the required Conflict of Interest statement on file for each member of TG 348 and determined that disclosure of potential Conflicts of Interest is an adequate management plan. Disclosures of potential Conflicts of Interest for each member of TG348 are found at the close of this document. The members of TG348 listed below attest that they have no potential Conflicts of Interest related to the subject matter or materials presented in this document. Susan Richardson, PhD, Chair; Ivan Buzurovic, PhD; Wesley Culberson, PhD; Claire Dempsey, PhD; Bruce Libby, PhD; Christopher Melhus, PhD; Robin Miller, MS; Samantha Simiele, PhD. The members of TG348 listed below disclose the following potential Conflict(s) of Interest related to subject matter or materials presented in this document. Daniel Scanderbeg, PhD––Varian Medical––speaker/consultant Merit Medical––speaker/consultant; Gil'ad Cohen, MS––Varian Medical––speaker.

References

    1. International Commission on Radiation Units and Measurements (ICRU) . Dose and Volume Specification for Reporting Intracavitary Brachytherapy in Gynecology . Report 38. 1985.
    1. Hilaris BS. Brachytherapy in cancer of the prostate: an historical perspective. Semin Surg Oncol. 1997;13(6). New York: John Wiley & Sons, Inc. -PubMed
    1. Scalliet P, Gerbaulet A, Dubray B. HDR versus LDR gynecological brachytherapy revisited. Radiother Oncol. 1993;28(2):118‐126. -PubMed
    1. International Atomic Energy Agency . Categorization of Radioactive Sources . Safety Standards Series No. RS‐G‐1.9. IAEA; 2005.
    1. Simmons G. Structural Shielding Design and Evaluation for Medical Use of X‐Rays & Gamma Rays of Energies Up to 10 meV . NCRP Report No. 49. NCRP Publications; 1976: 126. $3.50. (1978): 228‐228.

Publication types

MeSH terms

LinkOut - more resources